Evidence map›Paper›PMID 34908457›Full record

ArticlemSphere2021

Detection of Minority Variants and Mixed Infections in Mycobacterium tuberculosis by Direct Whole-Genome Sequencing on Noncultured Specimens Using a Specific-DNA Capture Strategy.

Nuria Lozano, Val F Lanza, Julia Suárez-González, Marta Herranz, Pedro J Sola-Campoy, Cristina Rodríguez-Grande, Sergio Buenestado-Serrano, María Jesús Ruiz-Serrano, Griselda Tudó, Fernando Alcaide and 3 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Resistome and virulome determination inMicrobiology spectrum · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Aerosolization of viableProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Genomic markers of drug resistance inJournal of clinical microbiology · 2023
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Nuria LozanoInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Val F LanzaBioinformatics Unit IRYCIS, University Hospital Ramón y Cajal, Madrid, Spain.
Julia Suárez-GonzálezInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Marta HerranzInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Pedro J Sola-CampoyInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Cristina Rodríguez-GrandeInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Sergio Buenestado-SerranoInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
María Jesús Ruiz-SerranoInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Griselda TudóServei de Microbiologia, Hospital Clinic-CDB, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Fernando AlcaideServicio de Microbiología, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-4097-1499
Patricia MuñozInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.ORCID 0000-0001-5706-5583
Darío García de ViedmaInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.ORCID 0000-0003-3647-7110
Laura Pérez-LagoInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.ORCID 0000-0001-5249-7619
Hospital General Universitario Gregorio Marañón · ESBellvitge University Hospital · ESCentro de Investigación Biomédica en Red · ESDepartament de Salut · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detection of mixed Mycobacterium tuberculosis (MTB) infections is essential, particularly when resistance mutations are present in minority bacterial populations that may affect patients' disease evolution and treatment. Whole-genome sequencing (WGS) has extended the amount of key information available for the diagnosis of MTB infection, including the identification of mixed infections. Having genomic information at diagnosis for early intervention requires carrying out WGS directly on the clinical samples. However, few studies have been successful with this approach due to the low representation of MTB DNA in sputa. In this study, we evaluated the ability of a strategy based on specific MTB DNA enrichment by using a newly designed capture platform (MycoCap) to detect minority variants and mixed infections by WGS on controlled mixtures of MTB DNAs in a simulated sputum genetic background. A pilot study was carried out with 12 samples containing 98% of a DNA pool from sputa of patients without MTB infection and 2% of MTB DNA mixtures at different proportions. Our strategy allowed us to generate sequences with a quality equivalent to those obtained from culture: 62.5× depth coverage and 95% breadth coverage (for at least 20× reads). Assessment of minority variant detection was carried out by manual analysis and allowed us to identify heterozygous positions up to a 95:5 ratio. The strategy also automatically distinguished mixed infections up to a 90:10 proportion. Our strategy efficiently captures MTB DNA in a nonspecific genetic background, allows detection of minority variants and mixed infections, and is a promising tool for performing WGS directly on clinical samples.

Indexed as

Whole Genome SequencingDNA, BacterialGenome, BacterialHumansMycobacterium tuberculosisPilot ProjectsSputumTuberculosisDNA, Bacterialheteroresistancemixed infectionsMycobacterium tuberculosisspecific-DNA capturewhole-genome sequencing

Identifiers

PMID34908457
PMCPMC8673255
OpenAlexW4200087645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.